274 related articles for article (PubMed ID: 21601373)
1. Dynamic contrast-enhanced magnetic resonance imaging as a predictor of outcome in head-and-neck squamous cell carcinoma patients with nodal metastases.
Shukla-Dave A; Lee NY; Jansen JF; Thaler HT; Stambuk HE; Fury MG; Patel SG; Moreira AL; Sherman E; Karimi S; Wang Y; Kraus D; Shah JP; Pfister DG; Koutcher JA
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1837-44. PubMed ID: 21601373
[TBL] [Abstract][Full Text] [Related]
2. Dynamic contrast-enhanced MRI, diffusion-weighted MRI and
Ng SH; Liao CT; Lin CY; Chan SC; Lin YC; Yen TC; Chang JT; Ko SF; Fan KH; Wang HM; Yang LY; Wang JJ
Eur Radiol; 2016 Nov; 26(11):4162-4172. PubMed ID: 26911889
[TBL] [Abstract][Full Text] [Related]
3. Tumor metabolism and perfusion in head and neck squamous cell carcinoma: pretreatment multimodality imaging with 1H magnetic resonance spectroscopy, dynamic contrast-enhanced MRI, and [18F]FDG-PET.
Jansen JF; Schöder H; Lee NY; Stambuk HE; Wang Y; Fury MG; Patel SG; Pfister DG; Shah JP; Koutcher JA; Shukla-Dave A
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):299-307. PubMed ID: 21236594
[TBL] [Abstract][Full Text] [Related]
4. Dynamic contrast-enhanced MRI histogram parameters predict progression-free survival in patients with advanced esophageal squamous carcinoma receiving concurrent chemoradiotherapy.
Xu L; Ge X; Sun N; Liu X
Acta Radiol; 2020 Oct; 61(10):1316-1325. PubMed ID: 32053003
[TBL] [Abstract][Full Text] [Related]
5. Clinical utility of multimodality imaging with dynamic contrast-enhanced MRI, diffusion-weighted MRI, and 18F-FDG PET/CT for the prediction of neck control in oropharyngeal or hypopharyngeal squamous cell carcinoma treated with chemoradiation.
Ng SH; Lin CY; Chan SC; Lin YC; Yen TC; Liao CT; Chang JT; Ko SF; Wang HM; Chang CJ; Wang JJ
PLoS One; 2014; 9(12):e115933. PubMed ID: 25531391
[TBL] [Abstract][Full Text] [Related]
6. Dynamic contrast-enhanced MR imaging predicts local control in oropharyngeal or hypopharyngeal squamous cell carcinoma treated with chemoradiotherapy.
Ng SH; Lin CY; Chan SC; Yen TC; Liao CT; Chang JT; Ko SF; Wang HM; Huang SF; Lin YC; Wang JJ
PLoS One; 2013; 8(8):e72230. PubMed ID: 23951300
[TBL] [Abstract][Full Text] [Related]
7. Correlation of a priori DCE-MRI and (1)H-MRS data with molecular markers in neck nodal metastases: Initial analysis.
Jansen JF; Carlson DL; Lu Y; Stambuk HE; Moreira AL; Singh B; Patel SG; Kraus DH; Wong RJ; Shaha AR; Shah JP; Shukla-Dave A
Oral Oncol; 2012 Aug; 48(8):717-22. PubMed ID: 22366441
[TBL] [Abstract][Full Text] [Related]
8. Pretreatment diffusion-weighted and dynamic contrast-enhanced MRI for prediction of local treatment response in squamous cell carcinomas of the head and neck.
Chawla S; Kim S; Dougherty L; Wang S; Loevner LA; Quon H; Poptani H
AJR Am J Roentgenol; 2013 Jan; 200(1):35-43. PubMed ID: 23255739
[TBL] [Abstract][Full Text] [Related]
9. Prognostic role of diffusion weighted and dynamic contrast-enhanced MRI in loco-regionally advanced head and neck cancer treated with concomitant chemoradiotherapy.
Garbajs M; Strojan P; Surlan-Popovic K
Radiol Oncol; 2019 Mar; 53(1):39-48. PubMed ID: 30840595
[TBL] [Abstract][Full Text] [Related]
10. Prediction of disease-free survival in patients with squamous cell carcinomas of the head and neck using dynamic contrast-enhanced MR imaging.
Chawla S; Kim S; Loevner LA; Hwang WT; Weinstein G; Chalian A; Quon H; Poptani H
AJNR Am J Neuroradiol; 2011 Apr; 32(4):778-84. PubMed ID: 21349969
[TBL] [Abstract][Full Text] [Related]
11. Application of Dynamic Contrast-Enhanced MRI Parameters for Differentiating Squamous Cell Carcinoma and Malignant Lymphoma of the Oropharynx.
Park M; Kim J; Choi YS; Lee SK; Koh YW; Kim SH; Choi EC
AJR Am J Roentgenol; 2016 Feb; 206(2):401-7. PubMed ID: 26797371
[TBL] [Abstract][Full Text] [Related]
12. Primary tumor volume is an important predictor of clinical outcomes among patients with locally advanced squamous cell cancer of the head and neck treated with definitive chemoradiotherapy.
Strongin A; Yovino S; Taylor R; Wolf J; Cullen K; Zimrin A; Strome S; Regine W; Suntharalingam M
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1823-30. PubMed ID: 21549516
[TBL] [Abstract][Full Text] [Related]
13. Prediction of distant metastases in patients with squamous cell carcinoma of head and neck using DWI and DCE-MRI.
Chawla S; Kim SG; Loevner LA; Wang S; Mohan S; Lin A; Poptani H
Head Neck; 2020 Nov; 42(11):3295-3306. PubMed ID: 32737951
[TBL] [Abstract][Full Text] [Related]
14. DCE-MRI of locally-advanced carcinoma of the uterine cervix: Tofts analysis versus non-model-based analyses.
Lund KV; Simonsen TG; Kristensen GB; Rofstad EK
Radiat Oncol; 2020 Apr; 15(1):79. PubMed ID: 32293487
[TBL] [Abstract][Full Text] [Related]
15. Risk Factors Associated with Disease Recurrence in Patients with Stage III/IV Squamous Cell Carcinoma of the Oral Cavity Treated with Surgery and Postoperative Radiotherapy.
Noble AR; Greskovich JF; Han J; Reddy CA; Nwizu TI; Khan MF; Scharpf J; Adelstein DJ; Burkey BB; Koyfman SA
Anticancer Res; 2016 Feb; 36(2):785-92. PubMed ID: 26851040
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic parameters derived from dynamic contrast enhanced MRI of cervical cancers predict chemoradiotherapy outcome.
Andersen EK; Hole KH; Lund KV; Sundfør K; Kristensen GB; Lyng H; Malinen E
Radiother Oncol; 2013 Apr; 107(1):117-22. PubMed ID: 23333024
[TBL] [Abstract][Full Text] [Related]
17. Relation between the level of lymph node metastasis and survival in locally advanced head and neck squamous cell carcinoma.
Xing Y; Zhang J; Lin H; Gold KA; Sturgis EM; Garden AS; Lee JJ; William WN
Cancer; 2016 Feb; 122(4):534-45. PubMed ID: 26554754
[TBL] [Abstract][Full Text] [Related]
18. Aberrant methylation inactivates somatostatin and somatostatin receptor type 1 in head and neck squamous cell carcinoma.
Misawa K; Misawa Y; Kondo H; Mochizuki D; Imai A; Fukushima H; Uehara T; Kanazawa T; Mineta H
PLoS One; 2015; 10(3):e0118588. PubMed ID: 25734919
[TBL] [Abstract][Full Text] [Related]
19. Prediction of response to chemoradiation therapy in squamous cell carcinomas of the head and neck using dynamic contrast-enhanced MR imaging.
Kim S; Loevner LA; Quon H; Kilger A; Sherman E; Weinstein G; Chalian A; Poptani H
AJNR Am J Neuroradiol; 2010 Feb; 31(2):262-8. PubMed ID: 19797785
[TBL] [Abstract][Full Text] [Related]
20. Voxelwise comparison of perfusion parameters estimated using dynamic contrast enhanced (DCE) computed tomography and DCE-magnetic resonance imaging in locally advanced cervical cancer.
Kallehauge J; Nielsen T; Haack S; Peters DA; Mohamed S; Fokdal L; Lindegaard JC; Hansen DC; Rasmussen F; Tanderup K; Pedersen EM
Acta Oncol; 2013 Oct; 52(7):1360-8. PubMed ID: 24003852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
